Driving impairment
This medicine may affect your ability to drive or use machines.
Leaflet PLEGOMAZIN 25mg / 5ml solution for injection
- Product code:
- W07612001
- Quantity:
- 10
- Indicated for:
- schizophrenia; bipolar disorder
- Route of administration:
- injectable
- Substance:
- chlorpromazine (antipsychotic)
- ATC
- N05AA01 — Nervous system | Antipsychotics | Phenothiazines with aliphatic side-chain
Precautions:
Dizziness / vertigo
This medicine may cause dizziness or vertigo.
Hyperglycemia
This medicine may increase blood sugar.
Cardiac risk / QT prolongation / arrhythmias
This medicine may increase the risk of heart rhythm disturbances.
Seizure risk
This medicine may increase the risk of seizures.
Drowsiness / sedation
This medicine may cause drowsiness or reduced alertness.
Chlorpromazine is a phenothiazine antipsychotic used for the treatment of schizophrenia, bipolar disorder, and other psychiatric conditions. It is also used to relieve severe nausea and vomiting.
The medication is administered orally, intramuscularly, or intravenously, as directed by a doctor. It is important for patients to follow the prescribed dosage and not discontinue treatment without consulting their doctor.
Patients should be aware of potential side effects, such as drowsiness, dizziness, or dry mouth. It is important to inform the doctor of any unusual symptoms.
Common side effects include drowsiness, dizziness, dry mouth, and constipation. In rare cases, severe reactions such as neuroleptic malignant syndrome or tardive dyskinesia may occur. Patients should be informed of these risks before starting treatment.
The medication is administered orally, intramuscularly, or intravenously, as directed by a doctor. It is important for patients to follow the prescribed dosage and not discontinue treatment without consulting their doctor.
Patients should be aware of potential side effects, such as drowsiness, dizziness, or dry mouth. It is important to inform the doctor of any unusual symptoms.
Common side effects include drowsiness, dizziness, dry mouth, and constipation. In rare cases, severe reactions such as neuroleptic malignant syndrome or tardive dyskinesia may occur. Patients should be informed of these risks before starting treatment.
General data about PLEGOMAZIN 25mg / 5ml
- Substance:
- chlorpromazine
- Date of latest medicines list:
- 01-07-2013
- Product code:
- W07612001
- Concentration:
- 25mg / 5ml
- Pharmaceutical form:
- solution for injection
- Quantity:
- 10
- Product type:
- Generic medicine
- Prescription status:
- P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.